ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/25/2024
Back to search
Official data from USPTO
C
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000077212184Class
1, 5, 10, 42, 44
Filing
77212184
Registration
3849207
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
72
Latest update
09/25/2024
Trademark type
Combined
Nice classes
1, 5, 10, 42, 44
Filing date
06/21/2007
Registration date
09/21/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/04/2019
Last transaction
09/17/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
16
Owner location
MANNHEIM, DE
Examiner
FLETCHER, TRACY
Law office
M60
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of a stylized letter "C" with a vertical line passing through it, with the letter "C" being blurred to the left of the line and clear or in focus to the right of the vertical line.
Holders and representatives
Holders
ROCHE DIAGNOSTICS GMBH
ROCHE MTM LABORATORIES AG
MTM Laboratories AG
Representatives
Mona Gupta Roche Diagnostics Operations, Inc.
Technical classification
Nice Classes
Class 1Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industry and sciencediagnostic preparationsreagents and chemical test kits comprised of reagents for chemical analyses and reagents for medical research use for detection of cancerous conditionsneoplastic conditionsinflammatory conditionsinfectious conditionsdegenerative conditionsgenetically aberrant or diseased conditionsproliferatively aberrant or diseased conditionsvascular disease conditionspremalignant conditionsmalignant conditionscancer and inborn errors for scientific or research use
Class 5
Pharmaceutical and veterinary preparationspharmaceutical preparations for the treatment and prevention of neoplasticinflammatoryinfectiousdegenerativegeneticproliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditionscancer and inborn errors; veterinary preparations for the treatment and prevention of neoplasticinflammatoryinfectiousdegenerativegenetic and proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditionscancer and inborn errors in livestockcattlepigshorsesdeerelkmoosesheepdogscatsmiceratsmonkeysapes and birds; medical diagnostic reagents and kits comprised of medical diagnostic reagents and assays for detection of cancer and neoplasticinflammatoryinfectiousdegenerativegeneticproliferative and vascular diseases and for the detection of premalignant and malignant cancerous conditionscancer and inborn errors; medical diagnostic preparationsin-vitro and in-vivo diagnostic test kitsdiagnostic immunocytochemical kitsdiagnostic immunohistochemical kitsdiagnostic histology kitsdiagnostic cytology kitsdiagnostic liquid-immuno-assay kitsdiagnostic solid-phase immuno-assay kitsdiagnostic strip-testsdiagnostic dip-stick-testspoint of care testsdiagnostic lateral-flow assay kitsdiagnostic flow-through assay kitsdiagnostic immuno-chromatographic kitsall of the above-mentioned kits being for use in early diagnosisprognosisgradingmonitoringstagingpredictive therapy guidancepatient stratification or therapy guidance of premalignant and malignant conditionscancerinborn errors and infectiousgeneticproliferative or vascular diseases; medical diagnostic test strips and diagnostic dip-stick tests for use in early diagnosisprognosisgradingmonitoringstagingpredictive therapy guidancepatient stratification or therapy guidance of premalignant and malignant conditionscancerinborn errors and infectiousgeneticproliferative or vascular diseases
Class 10
Diagnostic testing machinespoint-of-care testing machinesdiagnostic liquid-immuno-assay machinesdiagnostic immunocytochemical machinesdiagnostic immunohistochemical machinesdiagnostic histology machinesdiagnostic cytology machinesdiagnostic solid-phase immuno assay machinesdiagnostic ELISA testing machinesdiagnostic immuno-chromatographic machinesall of the aforementioned machines being used to analyze and/or provide diagnostic test results and used in connection with early diagnosisprognosisgradingmonitoringstagingpredictive therapy guidancepatient stratification or therapy guidance of premalignant and malignant conditionscancerinborn errors and infectious and genetic diseases associated with cancerproliferative diseases associated with neoplastics and dysplastic conditions or vascular diseases as indicated above; medical diagnostic equipmentcontainers specially designed for storing and transporting medical samples in the nature of tubesmultiwell platescolumnsstripssticksbrushesall for sampling of medical samples from body cavities and epithelia; medical syringesneedles for medical usespatulas for medical samples and medical diagnostic testingmedical diagnostic testing swabsclothstamponsall for use in samplingstoringtransportingpreparingenrichingconcentratingtestinganalyzing and evaluating biological material and samples in connection with early diagnosisprognosisgradingmonitoringstagingpredictive therapy guidancepatient stratification and therapy guidance of premalignant and malignant conditionscancerinborn errors and infectiousgeneticproliferative and vascular diseases as indicated above; diagnostic nucleic acid detection machinesdiagnostic nucleic acid amplification machinesdiagnostic immuno-histology machines and diagnostic immuno-cytology machines all used to analyze and/or provide diagnostic test results and used in connection with early diagnosisprognosisgradingmonitoringstagingpredictive therapy guidancepatient stratification or therapy guidance of premalignant and malignant conditionscancerinborn errors and infectious and genetic diseases associated with cancerproliferative diseases associated with neoplastics and dysplastic conditions or vascular diseases as indicated above; medical diagnostic apparatuses and instrumentshand-heldtable-top and floor-standing centrifugalgravitational-separatingelectrophoreticchromatographicconductometricpotentiometricspectrometricspectro-photometricradiologic electromagnetic-resonancehistologicalmicroscopic and in-vivo-imaging machines and apparatuses for use in preparingenrichingconcentratingtestinganalyzing and evaluating of biological material and samples in connection with early diagnosisprognosisgradingmonitoringstagingpredictive therapy guidancepatient stratification and therapy guidance of premalignant and malignant conditionscancerinborn errors and infectiousgeneticproliferative and vascular diseases as indicated above for clinical and medical laboratory use
Class 42
Scientific and technological services and research and design relating theretoindustrial analysis and research servicesdesign and development of computer hardware and softwarescientific analysis in the fields of chemistrybiology and molecular biologylaboratory research in the field of molecular biology; laboratory research in the fields of pharmaceutics and food technology; providing research in the fields of pharmaceuticalchemical and diagnostic research; research and development of pharmaceutical products and substances for others; scientific research in the nature of scientific information research services; chemicalbiologicalmolecular biology and pharmacogenomic analysis services
Class 44
Medical servicesveterinary servicesmedical diagnostic services and provision of medical diagnostic information in the field of detection of neoplasticinflammatoryinfectiousdegenerativegeneticproliferative and vascular diseasespremalignant and malignant cancerous conditionscancer and inborn errors; veterinary diagnostic services and provision of veterinary diagnostic information in the field of detection of neoplasticinflammatoryinfectiousdegenerativegeneticproliferative and vascular diseasespremalignant and malignant cancerous conditionscancer and inborn errors in livestockcattlepigshorsesdeerelkmoosesheepdogscatsmiceratsmonkeysapes and birds
Publications
History of USPTO decisions and trademark events.
72 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/13/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/13/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
09/13/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/13/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/13/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/09/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/09/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/09/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/09/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/09/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/09/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/05/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/05/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/05/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/05/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/05/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/05/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/10/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/10/2019
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/04/2019
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/04/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/04/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
10/02/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/02/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/02/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/21/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/10/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/10/2019
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/06/2017
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/06/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/05/2017
E815
TEAS SECTION 8 & 15 RECEIVED
03/20/2017
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
03/24/2014
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
03/24/2014
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/20/2012
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/20/2012
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/18/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
09/21/2010
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
08/14/2010
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/10/2010
IUCN
NOTICE OF ALLOWANCE CANCELLED
08/09/2010
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
08/09/2010
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
02/09/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/17/2009
PUBO
PUBLISHED FOR OPPOSITION
11/17/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/09/2009
ALIE
ASSIGNED TO LIE
10/07/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/06/2009
DMCC
DATA MODIFICATION COMPLETED
10/06/2009
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/04/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/04/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/02/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/30/2009
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/30/2009
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
03/31/2009
GNSI
INQUIRY TO SUSPENSION E-MAILED
03/31/2009
CNSI
SUSPENSION INQUIRY WRITTEN
03/31/2009
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
03/31/2009
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/29/2008
GNSL
LETTER OF SUSPENSION E-MAILED
09/29/2008
CNSL
SUSPENSION LETTER WRITTEN
09/29/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/06/2008
ALIE
ASSIGNED TO LIE
05/06/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/05/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/05/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/04/2007
GNRT
NON-FINAL ACTION E-MAILED
11/04/2007
CNRT
NON-FINAL ACTION WRITTEN
11/04/2007
DOCK
ASSIGNED TO EXAMINER
09/24/2007
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
06/26/2007
NWAP
NEW APPLICATION ENTERED
06/25/2007
Continuous trademark protection
Get notified about every new filing that threatens C or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.